Comment on Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model.
作者信息
Zhang Yunwei, Zhang Hongji
机构信息
Department of Surgery, University of Virginia, Charlottesville, Virginia 22903, USA.
出版信息
Chin Med J (Engl). 2025 Jan 24;138(5):540-1. doi: 10.1097/CM9.0000000000003492.
Abstract
摘要
相似文献
1
Comment on Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model.关于高三尖杉酯碱通过增强小鼠模型中调节性T细胞诱导促进心脏同种异体移植接受的评论。
Chin Med J (Engl). 2025 Jan 24;138(5):540-1. doi: 10.1097/CM9.0000000000003492.
2
Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model.高三尖杉酯碱通过增强调节性 T 细胞诱导促进心脏移植耐受。
Chin Med J (Engl). 2024 Jun 20;137(12):1453-1464. doi: 10.1097/CM9.0000000000002813. Epub 2023 Nov 14.
3
Homoharringtonine Promotes FTO Degradation to Suppress LILRB4-Mediated Immune Evasion in Acute Monocytic Leukaemia.高三尖杉酯碱促进FTO降解以抑制急性单核细胞白血病中LILRB4介导的免疫逃逸。
Cell Prolif. 2025 Jul 1:e70090. doi: 10.1111/cpr.70090.
4
Enhanced Costimulation Blockade With αCD154, αCD2, and αCD28 to Promote Heart Allograft Tolerance in Nonhuman Primates.使用αCD154、αCD2和αCD28增强共刺激阻断以促进非人灵长类动物心脏同种异体移植耐受
Transplantation. 2025 Jun 1;109(6):e287-e296. doi: 10.1097/TP.0000000000005315. Epub 2025 Jan 9.
5
Inhibition of G protein-coupled receptor 68 using homoharringtonine attenuates chronic kidney disease-associated cardiac impairment.用高三尖杉酯碱抑制 G 蛋白偶联受体 68 可减轻慢性肾脏病相关的心脏损伤。
Transl Res. 2024 Jul;269:31-46. doi: 10.1016/j.trsl.2024.02.004. Epub 2024 Feb 23.
6
Immunosuppressive T-cell antibody induction for heart transplant recipients.心脏移植受者的免疫抑制性T细胞抗体诱导治疗
Cochrane Database Syst Rev. 2013 Dec 2;2013(12):CD008842. doi: 10.1002/14651858.CD008842.pub2.
7
Sex-determining region Y-Box 4 promotes the progression of advanced hepatocellular carcinoma and enhances regulatory T-cell infiltration and immune suppression.性别决定区Y框蛋白4促进晚期肝细胞癌进展并增强调节性T细胞浸润及免疫抑制。
Cytojournal. 2025 Jun 2;22:56. doi: 10.25259/Cytojournal_27_2025. eCollection 2025.
8
Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice.共刺激阻断剂递送至淋巴结可促进小鼠移植耐受。
J Clin Invest. 2022 Dec 15;132(24):e159672. doi: 10.1172/JCI159672.
9
Rational combination of homoharringtonine to selectively target FLT3-ITD acute myeloid leukemia through synthetic lethality.高三尖杉酯碱通过合成致死效应与FLT3-ITD急性髓系白血病选择性靶向的合理组合。
Phytomedicine. 2025 Oct;146:157124. doi: 10.1016/j.phymed.2025.157124. Epub 2025 Jul 29.
10
Homoharringtonine in Relapsed/Refractory Paediatric T-Cell Acute Lymphoblastic Leukaemia-A Case Series and a Report on the Use of In Vitro Drug Profiling.高三尖杉酯碱治疗复发/难治性儿童T细胞急性淋巴细胞白血病——病例系列及体外药物分析应用报告
Pediatr Blood Cancer. 2025 Apr;72(4):e31576. doi: 10.1002/pbc.31576. Epub 2025 Jan 29.
本文引用的文献
1
Homoharringtonine promotes heart allograft acceptance by enhancing regulatory T cells induction in a mouse model.高三尖杉酯碱通过增强调节性 T 细胞诱导促进心脏移植耐受。
Chin Med J (Engl). 2024 Jun 20;137(12):1453-1464. doi: 10.1097/CM9.0000000000002813. Epub 2023 Nov 14.
2
Cardiac xenotransplantation: from concept to clinic.心脏异种移植：从概念到临床。
Cardiovasc Res. 2023 Feb 3;118(18):3499-3516. doi: 10.1093/cvr/cvac180.
3
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the International Society for Heart and Lung Transplantation.实体器官移植中维持免疫抑制使用的共识建议：得到了美国临床药学学院、美国移植学会和国际心肺移植学会的认可。
Pharmacotherapy. 2022 Aug;42(8):599-633. doi: 10.1002/phar.2716.
4
Noninvasive biomarkers for prediction and diagnosis of heart transplantation rejection.用于心脏移植排斥反应预测和诊断的非侵入性生物标志物。
Transplant Rev (Orlando). 2021 Jan;35(1):100590. doi: 10.1016/j.trre.2020.100590. Epub 2020 Nov 21.
5
Chronic Rejection of Cardiac Allografts Is Associated With Increased Lymphatic Flow and Cellular Trafficking.心脏同种异体移植物的慢性排斥与淋巴液流量增加和细胞迁移有关。
Circulation. 2018 Jan 30;137(5):488-503. doi: 10.1161/CIRCULATIONAHA.117.028533. Epub 2017 Aug 3.
Zotero 插件